Report Sections

See All Reports

  • HP:0002020: Gastroesophageal reflux
  • Pneumonia (359) Respiratory tract infection (38) Neoplasm (36) Abnormality of the cardiovascular system (34) Diabetes mellitus (33) Depressivity (29) Acute kidney injury (27) Hypoxemia (26) Hypertension (24) Abnormal lung morphology (24) Thromboembolism (22) Anosmia (20) Myocardial infarction (20) Arthritis (19) Type II diabetes mellitus (18) Stroke (16) Pulmonary embolism (16) Mental deterioration (15) Abnormality of coagulation (15) Pulmonary fibrosis (15) Chronic pulmonary obstruction (15) Abnormality of the kidney (14) Autistic behavior (14) Rheumatoid arthritis (14) Leukemia (14) Interstitial pneumonitis (14) Pulmonary obstruction (14) Asthma (13) Chronic pain (13) Congestive heart failure (12) Deep venous thrombosis (12) Neoplasm of the lung (12) Autism (11) Obesity (11) Respiratory distress (11) Colitis (11) Ulcerative colitis (11) Crohn's disease (11) Type I diabetes mellitus (10) Abnormality of the liver (9) Coronary artery atherosclerosis (9) Inflammation of the large intestine (9) Pulmonary insufficiency (9) Chronic kidney disease (9) Myocarditis (9) Behavioral abnormality (8) Psychosis (8) Dementia (8) Alzheimer disease (8) Carcinoma (8) Low levels of vitamin D (8) Sepsis (8) Infertility (7) Peripheral arterial stenosis (7) Renal insufficiency (6) Lymphopenia (6) Dysphagia (6) Lymphoma (6) Systemic lupus erythematosus (6) Osteoarthritis (6) Breast carcinoma (6) Psoriasiform dermatitis (6) Abnormality of the gastrointestinal tract (6) Fatigue (6) Encephalopathy (5) Premature birth (5) Bronchiectasis (5) Difficulty walking (5) Gastroparesis (5) Immunodeficiency (5) Obstructive sleep apnea (5) Autoimmunity (5) Knee osteoarthritis (5) Sleep apnea (5) Prostate cancer (5) Allergy (5) Non-small cell lung carcinoma (5) Schizophrenia (5) Neoplasm of the large intestine (5) Seizure (4) Hepatic fibrosis (4) Cardiac arrest (4) Weight loss (4) Migraine (4) Pulmonary arterial hypertension (4) Abnormal intestine morphology (4) Neoplasm of the pancreas (4) Colon cancer (4) Malnutrition (4) Paroxysmal atrial fibrillation (4) Disseminated intravascular coagulation (4) Attention deficit hyperactivity disorder (4) Inflammatory abnormality of the skin (4) Neoplasm of head and neck (4) Endometriosis (4) Addictive behavior (4) Hypercoagulability (4) Insomnia (4) Obsessive-compulsive behavior (3) Eczema (3) Atopic dermatitis (3) Spastic diplegia (3) Abnormal heart morphology (3) Cardiomyopathy (3) Fever (3) Hypothermia (3) Headache (3) Celiac disease (3) Reduced factor VIII activity (3) Lymphoid leukemia (3) Renal cell carcinoma (3) Abnormal anterior horn cell morphology (3) Amyotrophic lateral sclerosis (3) Cystoid macular edema (3) Arrhythmia (3) Cutaneous melanoma (3) Pulmonary edema (3) Ovarian neoplasm (3) Neuroendocrine neoplasm (3) Hypogeusia (2) Hearing impairment (2) Abnormality of the eye (2) Visual impairment (2) Conjunctivitis (2) Cataract (2) Uveitis (2) Agoraphobia (2) Abnormality of the endocrine system (2) Abnormality of the skin (2) Jaundice (2) Lymphedema (2) Spasticity (2) Meningitis (2) Abnormal joint morphology (2) Hepatic steatosis (2) Hepatic failure (2) Tachycardia (2) Angina pectoris (2) Pancreatitis (2) Abnormality of blood and blood-forming tissues (2) Thrombocytopenia (2) Autoimmune thrombocytopenia (2) Gout (2) Diarrhea (2) Gastroesophageal reflux (2) Apnea (2) Neurodegeneration (2) Alopecia of scalp (2) Mutism (2) Transient ischemic attack (2) Hyperkinetic movements (2) Polyphagia (2) Hypotension (2) Atherosclerosis (2) Hypoventilation (2) Squamous cell carcinoma (2) Myelodysplasia (2) Back pain (2) Low back pain (2) Muscular dystrophy (2) Stillbirth (2) Acute myeloid leukemia (2) Lymphoproliferative disorder (2) Myeloproliferative disorder (2) Multiple myeloma (2) Intervertebral disc degeneration (2) Stridor (2) Postprandial hyperglycemia (2) Hemeralopia (2) Arteritis (2) Hepatitis (2) Glioblastoma multiforme (2) Cervix cancer (2) Small cell lung carcinoma (2) Endocarditis (2) Toxemia of pregnancy (2) Myositis (2) Mania (2) Urinary retention (1) Urinary incontinence (1) Nephritis (1) Menorrhagia (1) Xerostomia (1) Otitis media (1) Conductive hearing impairment (1) Amblyopia (1) Periodontitis (1) IgA deposition in the glomerulus (1) Enuresis (1) Hypoparathyroidism (1) Adrenal insufficiency (1) Hyperaldosteronism (1) Osteopenia (1) Urticaria (1) Angiokeratoma corporis diffusum (1) Cholecystitis (1) Keratoconjunctivitis (1) Intellectual disability (1) Hemiparesis (1) Polyneuropathy (1) Syncope (1) Cerebral hemorrhage (1) Hepatocellular carcinoma (1) Intrauterine growth retardation (1) Hoarse voice (1) Dysphonia (1) Weak voice (1) Sudden cardiac death (1) Aortic valve stenosis (1) Bradycardia (1) Torsade de pointes (1) Atrioventricular block (1) Premature rupture of membranes (1) Dehydration (1) Constipation (1) Anorexia (1) Esophageal varix (1) Chorea (1) Status epilepticus (1) Subarachnoid hemorrhage (1) Abnormality of the spinal cord (1) Memory impairment (1) Encephalitis (1) Spina bifida (1) Language impairment (1) Waddling gait (1) Increased intracranial pressure (1) Biliary cirrhosis (1) Dilatation (1) Osteomyelitis (1) Central apnea (1) Hypokalemia (1) Hyponatremia (1) Hyperphosphatemia (1) Skeletal muscle atrophy (1) Male infertility (1) Spondylolisthesis (1) Myalgia (1) Bruxism (1) Neonatal death (1) Increased body weight (1) Intermittent claudication (1) Thrombophlebitis (1) Chronic bronchitis (1) Ventricular tachycardia (1) Acute myelomonocytic leukemia (1) Dilatation of the cerebral artery (1) Coronary artery stenosis (1) Venous insufficiency (1) Chronic lymphatic leukemia (1) Abnormality of bone marrow cell morphology (1) Hypersensitivity pneumonitis (1) Intraalveolar phospholipid accumulation (1) Neoplasm of the genitourinary tract (1) Neoplasm of the skin (1) Female infertility (1) Benign prostatic hyperplasia (1) Hip osteoarthritis (1) Bladder neoplasm (1) Stomatitis (1) Uterine neoplasm (1) Intestinal atresia (1) Placental abruption (1) Sinus tachycardia (1) Bronchiolitis (1) Erythroid hypoplasia (1) Asterixis (1) Hodgkin lymphoma (1) B-cell lymphoma (1) Ciliary dyskinesia (1) Myeloid leukemia (1) Chronic myelomonocytic leukemia (1) Morphea (1) Bronchitis (1) Hypercapnia (1) Pain (1) Retinal vein occlusion (1) Vasovagal syncope (1) Heart block (1) Cough (1) Neonatal asphyxia (1) Dyspareunia (1) Heart murmur (1) Cardiogenic shock (1) Cholangitis (1) Cholangiocarcinoma (1) Vulvar neoplasm (1) Neonatal sepsis (1) Glue ear (1) Abnormality of movement (1) Subdural hemorrhage (1) Biliary tract neoplasm (1) Nasal polyposis (1) Eclampsia (1) Esophagitis (1) Vaginal neoplasm (1) Cellulitis (1) Angioedema (1) Self-injurious behavior (1) Gastrointestinal stroma tumor (1) Bulimia (1) Neoplasm of the rectum (1) Chest pain (1) Atelectasis (1) Lymphocytosis (1) Polymenorrhea (1)

    HP:0002020: Gastroesophageal reflux

    Developed by Shray Alag, The Harker School
    Sections: Correlations, Clinical Trials, and HPO

    Correlations computed by analyzing all clinical trials.

    Navigate: Clinical Trials and HPO


    Correlated Drug Terms (7)


    Name (Synonyms) Correlation
    drug2613 None - NA Wiki 0.71
    drug2395 Mindfulness training Wiki 0.71
    drug3798 Subacute rehabilitation Wiki 0.71
    Name (Synonyms) Correlation
    drug2880 Personalized ambulatory training Wiki 0.71
    drug1875 IW-3718 Wiki 0.71
    drug1331 Early rehabilitation Wiki 0.71
    drug4650 placebo Wiki 0.18

    Correlated MeSH Terms (4)


    Name (Synonyms) Correlation
    D005764 Gastroesophageal Reflux NIH 1.00
    D004942 Esophagitis, Peptic NIH 0.71
    D004932 Esophageal and Gastric Varices NIH 0.71
    Name (Synonyms) Correlation
    D003108 Colonic Diseases NIH 0.71

    Correlated HPO Terms (1)


    Name (Synonyms) Correlation
    HP:0002040 Esophageal varix HPO 0.71

    Clinical Trials

    Navigate: Correlations   HPO

    There are 2 clinical trials


    1 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial of Oral IW-3718 Administered to Patients With Gastroesophageal Reflux Disease While Receiving Proton Pump Inhibitors

    The objective of this study is to evaluate the safety and efficacy of IW-3718 administered to patients with GERD who continue to have persistent symptoms, such as heartburn and regurgitation, while receiving once-daily (QD), standard-dose proton pump inhibitors (PPIs).

    NCT03561090
    Conditions
    1. Gastroesophageal Reflux Disease (GERD)
    Interventions
    1. Drug: IW-3718
    2. Drug: placebo
    MeSH:Gastroesophageal Reflux Esophagitis, Peptic
    HPO:Gastroesophageal reflux

    Primary Outcomes

    Measure: Proportion of Overall Heartburn Responders

    Time: Week 8

    Secondary Outcomes

    Measure: Proportion of Overall Heartburn Responders Among Participants With a Baseline Weekly Heartburn Severity Score (WHSS) ≥ 3

    Time: Week 8

    Measure: Percent Change From Baseline to Week 8 in WHSS

    Time: Baseline, Week 8

    Measure: Percent Change From Baseline to Week 8 in Weekly Regurgitation Frequency Score (WRFS)

    Time: Baseline, Week 8

    Measure: Proportion of Heartburn-Free (Daily Heartburn Severity Score [DHSS]=0) Days During the 8-Week Treatment Period

    Time: up to Week 8

    Measure: Proportion of Overall Regurgitation Responders

    Time: Week 8

    Measure: Proportion of Days When Heartburn Did Not Occur (DHSS=0) or Was Very Mild (DHSS=1) During the 8-Week Treatment Period

    Time: Week 8

    Measure: Proportion of Days When Regurgitation Did Not Occur (Daily Regurgitation Frequency Scores [DRFS]=0) or Rarely Occurred (DRFS=1) During the 8-Week Treatment Period

    Time: Week 8

    Measure: Proportion of Regurgitation-Free (DRFS=0) Days During the 8-Week Treatment Period

    Time: Week 8

    Measure: Change From Baseline to Week 8 in Each Modified Reflux Symptom Questionnaire Electronic Diary (mRESQ) Item

    Time: Baseline, Week 8

    Measure: Proportion of Nights With Difficulty Falling Asleep Due to GERD During the 8-Week Treatment Period

    Time: Week 8

    Measure: Proportion of Days With Nighttime Awakening Due to GERD During the 8-Week Treatment Period

    Time: Week 8

    Measure: Number of Degree of Relief (of Heartburn/Regurgitation/Overall GERD Symptoms) Responders

    Time: up to Week 8

    Measure: Change From Baseline to Week 8 in Heartburn/Regurgitation/Overall GERD Symptoms Bothersomeness

    Time: Baseline, Week 8

    Measure: Proportion of Days With Rescue Medication Use During the 8-Week Treatment Period

    Time: up to Week 8
    2 Endoscopy-related Phone Consultation During the COVID-19 Outbreak: Impact on Attendance and Patient/Consultant Perspectives From a Tertiary Australian Hospital

    The aim of this study is to evaluate patient and consultant experiences with phone consultations for endoscopy-related outpatient appointments during the COVID-19 outbreak.

    NCT04344964
    Conditions
    1. Colon Polyp
    2. Colon Disease
    3. Reflux, Gastroesophageal
    4. Varices, Esophageal
    Interventions
    1. Other: None - NA
    MeSH:Colonic Diseases Gastroesophageal Reflux Esophageal and Gastric Varices
    HPO:Esophageal varix Gastric varix Gastroesophageal reflux

    Primary Outcomes

    Description: percentage of patients that did not answer phone calls (at least 3 calls) or with documented FTA for the retrospective group.

    Measure: Failed to attend patients

    Time: 2 months

    Secondary Outcomes

    Description: Assessed through an online/hardcopy questionnaire based on previous studies on telehealth (adapted from Barsom et al. 2020 - MSF and PAT-VC questionnaires). These are mostly Likert-scale response mode statements.

    Measure: Patient satisfaction with the phone consult

    Time: 2 months

    Description: Assessed through an online/hardcopy questionnaire based on previous studies on telehealth (adapted from Barsom et al. 2020). These are mostly Likert-scale response mode statements.

    Measure: Consultant satisfaction with the phone consult

    Time: 2 months

    HPO Nodes


    HP:0002020: Gastroesophageal reflux
    Genes 453
    ZIC2 HLA-DQA1 TERT KCNA2 SLC1A4 POGZ COL7A1 NONO NRXN1 NODAL COL5A1 SHANK3 PGM3 LIMK1 SCN8A ERCC8 ORC6 CTHRC1 FOXG1 EXT2 COL7A1 EEF1A2 RHBDF2 SIX3 SYT1 ACTL6B GP1BB FGFR3 TYMP DSP MLXIPL HLA-DRB1 KAT6A CHMP1A SEC24C SYNJ1 SYT1 CPLX1 CAMK2B PAK1 LRP5 RNF125 STAG1 WWOX NSD2 SNRPB FBXL4 SLC25A24 DISP1 GAS1 FOXH1 MECP2 ELN MAGEL2 OCRL PSPH JMJD1C UFD1 CREBBP CCR6 HNRNPH2 ASXL1 FCSK DLL1 SIX3 ORC1 SEC31A ASPA GTF2I NECAP1 NUP62 NSD1 GABRB2 FOXG1 FOXH1 GABRA2 MUC5B DDOST CDON ADAR TCF4 NALCN TRAK1 GAS1 SCN3A STAG2 COL13A1 SLC46A1 TMTC3 COL5A2 SPOP CYFIP2 PIK3CD NODAL NUP214 BRAF TRIP4 CACNA1B VAMP1 KMT2A SHH DISP1 RAD21 MECP2 TRMT10C GLI2 COL1A1 SEC23A HIVEP2 ITCH RERE BLM DISP1 TSPYL1 TWNK SLC13A5 FGF8 PSAP GABRA5 TDGF1 SLC2A10 ATAD1 SLC19A2 GLI2 FGF8 NIPBL TRAPPC12 TWIST1 MECP2 FGFR1 HLA-DRB1 CREBBP GNAS TBX4 SLC9A6 LETM1 NIPBL SRPX2 ATN1 CDKL5 RPL10 FMR1 CDON GRIN2D STAG2 NEDD4L DNM1 SIX3 RETREG1 RAI1 LBR ATP11A SAMD9 CAMTA1 RAI1 LAMA2 DDOST PHGDH ORC4 RERE ALMS1 ZIC2 HDAC8 ATRX KCNQ2 PUF60 LONP1 GABRG2 RPL10 TOP3A FGF8 ABCA3 DPP9 CSPP1 SFTPA1 SHH TSPYL1 ARV1 STXBP1 SON CNTNAP2 RET STAG2 ABCD4 PCGF2 KCNQ3 NODAL SLC1A2 RRM2B SKI NOS1 PTCH1 ZIC2 SMC1A CLTC CTCF GAS1 CNTNAP1 STAC3 PIGN TCF4 NTRK2 KCNB1 TIMM22 NEXMIF DYRK1A ASCC1 KNSTRN FLCN CDON TECPR2 MEIS2 POLG CDKN1A HCN1 IRF5 MSL3 CCN2 CAV1 PTCH1 GMNN MAP3K7 GLI2 SLC6A3 CCDC47 TCF4 SLC25A1 FARSB AARS1 PACS1 RPL10 CHD7 SLC25A4 CENPT DHCR7 SCN9A COL13A1 PIGN SMC1A FAM13A CHAT NPHS1 COG7 DYRK1A SH2B1 SLC18A3 CDKN1B SMC1A MEN1 ASCL1 MRPS34 KIF1A FBN1 ADNP NRXN1 CCR6 CDK19 SETD2 AMER1 RREB1 SLC35A2 ARVCF ATRX NEPRO MSR1 CLIP2 TBX1 PIGT SETD5 POGZ SYNGAP1 PPP3CA GEMIN4 ERMARD SFTPC KIAA0586 KLHL7 PRKCSH BAZ1B ZSWIM6 WHCR MAP3K7 IRF5 RRM2B AFF4 RFC2 SIX3 AP3B2 TDGF1 EBF3 KAT6B CACNA1A CDKN2C SLC6A3 USP7 ATRX FGF12 SEMA3E SHANK3 SFTPA2 SLC35A2 CDON FLNA ADGRG1 KMT2A RAD21 ALDH18A1 CCDC22 MAGEL2 TBC1D24 PARN MAP1B PARS2 PPM1D MED12L GLRA1 RAI1 CAV1 ZIC2 PI4KA AFF4 ARID2 HDAC8 CDC6 SMG9 ALDH18A1 NONO FOXH1 EXT2 MYMK GPHN UBA5 ARF1 FGF8 PHOX2B SHROOM4 ATRX GABRD POLG2 EP300 KCNAB2 TGIF1 CRLF1 WAC POLG2 PIGN TERT DHCR7 ADAMTS2 PTCH1 HRAS ARFGEF2 AGRN TDGF1 ERCC6 SNAP25 SHH WNK1 ELP1 LTBP4 ASXL1 GLI2 MID1 SKI CLCN4 CREBBP DHDDS GAS1 FOXG1 WASHC5 GALC NEXMIF RERE TFAP2A COMT TBX1 TGIF1 FLNA GTF2IRD1 SLC5A7 NUS1 KCNA2 NFIX DEAF1 SKI PTCH1 UBA5 DALRD3 ADAT3 YWHAG SMC3 FOXH1 STAG1 TAF1 FLII NALCN CNKSR2 TGIF1 SALL1 SMC3 RTEL1 STN1 APC2 PIEZO2 PIEZO1 SZT2 SEC63 SLC6A5 GLRB TDGF1 DLL1 PORCN CCN2 SHH TGIF1 EHMT1 CTBP1 ATP7A FGFR1 MYO9A FGFRL1 CHRNA3 HLA-DQB1 POLG MMP1 ELN WDR26 CHAMP1 SOX5 ATP6V1A ELP1 POLR2A NODAL SYT2 DDC MCEE ATP6 TBL2 DLL1 ARNT2 MED12 CDKN2B SMC1A HIRA TERC IQSEC2 KIAA0319L DLL1 SSR4 GNB5 PRDM16 PYCR1 DISP1
    Protein Mutations 1
    D961H
    SNP 0

    HPO

    Alphabetical listing of all HPO terms. Navigate: Correlations   Clinical Trials


    HPO Nodes


    HP:0002020: Gastroesophageal reflux
    Genes 453
    ZIC2 HLA-DQA1 TERT KCNA2 SLC1A4 POGZ COL7A1 NONO NRXN1 NODAL COL5A1 SHANK3 PGM3 LIMK1 SCN8A ERCC8 ORC6 CTHRC1 FOXG1 EXT2 COL7A1 EEF1A2 RHBDF2 SIX3 SYT1 ACTL6B GP1BB FGFR3 TYMP DSP MLXIPL HLA-DRB1 KAT6A CHMP1A SEC24C SYNJ1 SYT1 CPLX1 CAMK2B PAK1 LRP5 RNF125 STAG1 WWOX NSD2 SNRPB FBXL4 SLC25A24 DISP1 GAS1 FOXH1 MECP2 ELN MAGEL2 OCRL PSPH JMJD1C UFD1 CREBBP CCR6 HNRNPH2 ASXL1 FCSK DLL1 SIX3 ORC1 SEC31A ASPA GTF2I NECAP1 NUP62 NSD1 GABRB2 FOXG1 FOXH1 GABRA2 MUC5B DDOST CDON ADAR TCF4 NALCN TRAK1 GAS1 SCN3A STAG2 COL13A1 SLC46A1 TMTC3 COL5A2 SPOP CYFIP2 PIK3CD NODAL NUP214 BRAF TRIP4 CACNA1B VAMP1 KMT2A SHH DISP1 RAD21 MECP2 TRMT10C GLI2 COL1A1 SEC23A HIVEP2 ITCH RERE BLM DISP1 TSPYL1 TWNK SLC13A5 FGF8 PSAP GABRA5 TDGF1 SLC2A10 ATAD1 SLC19A2 GLI2 FGF8 NIPBL TRAPPC12 TWIST1 MECP2 FGFR1 HLA-DRB1 CREBBP GNAS TBX4 SLC9A6 LETM1 NIPBL SRPX2 ATN1 CDKL5 RPL10 FMR1 CDON GRIN2D STAG2 NEDD4L DNM1 SIX3 RETREG1 RAI1 LBR ATP11A SAMD9 CAMTA1 RAI1 LAMA2 DDOST PHGDH ORC4 RERE ALMS1 ZIC2 HDAC8 ATRX KCNQ2 PUF60 LONP1 GABRG2 RPL10 TOP3A FGF8 ABCA3 DPP9 CSPP1 SFTPA1 SHH TSPYL1 ARV1 STXBP1 SON CNTNAP2 RET STAG2 ABCD4 PCGF2 KCNQ3 NODAL SLC1A2 RRM2B SKI NOS1 PTCH1 ZIC2 SMC1A CLTC CTCF GAS1 CNTNAP1 STAC3 PIGN TCF4 NTRK2 KCNB1 TIMM22 NEXMIF DYRK1A ASCC1 KNSTRN FLCN CDON TECPR2 MEIS2 POLG CDKN1A HCN1 IRF5 MSL3 CCN2 CAV1 PTCH1 GMNN MAP3K7 GLI2 SLC6A3 CCDC47 TCF4 SLC25A1 FARSB AARS1 PACS1 RPL10 CHD7 SLC25A4 CENPT DHCR7 SCN9A COL13A1 PIGN SMC1A FAM13A CHAT NPHS1 COG7 DYRK1A SH2B1 SLC18A3 CDKN1B SMC1A MEN1 ASCL1 MRPS34 KIF1A FBN1 ADNP NRXN1 CCR6 CDK19 SETD2 AMER1 RREB1 SLC35A2 ARVCF ATRX NEPRO MSR1 CLIP2 TBX1 PIGT SETD5 POGZ SYNGAP1 PPP3CA GEMIN4 ERMARD SFTPC KIAA0586 KLHL7 PRKCSH BAZ1B ZSWIM6 WHCR MAP3K7 IRF5 RRM2B AFF4 RFC2 SIX3 AP3B2 TDGF1 EBF3 KAT6B CACNA1A CDKN2C SLC6A3 USP7 ATRX FGF12 SEMA3E SHANK3 SFTPA2 SLC35A2 CDON FLNA ADGRG1 KMT2A RAD21 ALDH18A1 CCDC22 MAGEL2 TBC1D24 PARN MAP1B PARS2 PPM1D MED12L GLRA1 RAI1 CAV1 ZIC2 PI4KA AFF4 ARID2 HDAC8 CDC6 SMG9 ALDH18A1 NONO FOXH1 EXT2 MYMK GPHN UBA5 ARF1 FGF8 PHOX2B SHROOM4 ATRX GABRD POLG2 EP300 KCNAB2 TGIF1 CRLF1 WAC POLG2 PIGN TERT DHCR7 ADAMTS2 PTCH1 HRAS ARFGEF2 AGRN TDGF1 ERCC6 SNAP25 SHH WNK1 ELP1 LTBP4 ASXL1 GLI2 MID1 SKI CLCN4 CREBBP DHDDS GAS1 FOXG1 WASHC5 GALC NEXMIF RERE TFAP2A COMT TBX1 TGIF1 FLNA GTF2IRD1 SLC5A7 NUS1 KCNA2 NFIX DEAF1 SKI PTCH1 UBA5 DALRD3 ADAT3 YWHAG SMC3 FOXH1 STAG1 TAF1 FLII NALCN CNKSR2 TGIF1 SALL1 SMC3 RTEL1 STN1 APC2 PIEZO2 PIEZO1 SZT2 SEC63 SLC6A5 GLRB TDGF1 DLL1 PORCN CCN2 SHH TGIF1 EHMT1 CTBP1 ATP7A FGFR1 MYO9A FGFRL1 CHRNA3 HLA-DQB1 POLG MMP1 ELN WDR26 CHAMP1 SOX5 ATP6V1A ELP1 POLR2A NODAL SYT2 DDC MCEE ATP6 TBL2 DLL1 ARNT2 MED12 CDKN2B SMC1A HIRA TERC IQSEC2 KIAA0319L DLL1 SSR4 GNB5 PRDM16 PYCR1 DISP1
    Protein Mutations 1
    D961H
    SNP 0

    Reports

    Data processed on September 26, 2020.

    An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.

    Drug Reports   MeSH Reports   HPO Reports  

    Interventions

    4,180 reports on interventions/drugs

    MeSH

    691 reports on MeSH terms

    HPO

    263 reports on HPO terms

    All Terms

    Alphabetical index of all Terms

    Google Colab

    Python example via Google Colab Notebook